Frontier Medicines Corporation
1 clinical trials · Sponsor
◉ Watch Frontier Medicines Corporation
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors (NCT06244771) | Frontier Medicines Corporation | 2024-02-12 |
Track Frontier Medicines Corporation automatically
Every clearance here is in the API, with alerts when new ones post.